Author Guidelines
Editorial Board
About Us
Contact Us
Advertise
Subscribe
Issue Archive
Home
CME
CME Articles
CME Posttests
myCME
CME From AAPA
Departments
A Day in the Life
Ask a Librarian!
Case of the Month
Clinical Watch
Commentary
Critically Appraised Topic
Dermatology Digest
Diagnostic Imaging Review
Editorial
Emergency Medicine Notes
From the Academy
Genomics in PA Practice
Humane Medicine
Inside the AAPA Policy Manual
Interpreting ECGs
Letters
PA Quandaries
Pharmacology Consult
Quick Recertification Series
Sounding Board
The Surgical Patient
Topics in Infectious Diseases
What's New
When the Patient Asks
Women’s Health
Articles
AAPA Special Article
Case Reports
CME Articles
Review Articles
Surgical Reviews
The Surgical Patient
Research
Brief Report
Research Corner
Research Report
Current Issue
Current Articles
Digital Issue
Archive
Blogs
Atrial Kick: Cardiothoracic Surgery Perspectives
Health Disparities Blog
HIT Blog
Musings: The JAAPA Editorial Board Blog
Authors
Roadmap to Better Writing
Writing for Publication Webcasts
JAAPA Submission Guidelines
News
Drug Information
Medical News
Conference Coverage
Newsletters
AAPA Publications
Tools & Links
The Art of Medicine
Become a peer reviewer
Clinical Practice Guidelines
Complementary and Alternative Medicine
Drug Information
Evidence-Based Medicine
Genetics in Medicine
Medical Calculators
Online Textbooks
PA Profession
Pain
Patient Information
Substance Abuse
Videos
AAPA
AAPA Home
CME Calendar
CME Posttests
The PA Job Link
Annual Conference
Join AAPA
PA Census and Data
PA Competencies
AAPA Publications
Commentary
Online Only
PAPR Drug Information
Meetings & Conferences
Newsletters
Jobs
RSS
|
Login
|
Register
Pharmaceutical Advertising
Is banning direct-to-consumer advertising (DTCA) consistent with bioethical principles?
Kevin Michael O'Hara, MMSc, PA-C, AAHIVS
August 11, 2010
The impact of DTCA on patients' expectations and PAs' responsibility to provide bioethical treatment are reviewed.
Sponsored Links